<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01375309</url>
  </required_header>
  <id_info>
    <org_study_id>1675</org_study_id>
    <secondary_id>UMIN000002543</secondary_id>
    <nct_id>NCT01375309</nct_id>
  </id_info>
  <brief_title>Bifidobacterium Supplementation for Very Low Birth Weight Infants</brief_title>
  <acronym>Bifido(RCT)</acronym>
  <official_title>Effect of Bifidobacterium Bifidum Supplementation on Morbidity of Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tokyo Women's Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tokyo Women's Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Probiotic supplementation to preterm infants have been reported to be beneficial in neonatal
      intensive care unit (NICU). Our pilot study also showed accelerated feeding in preterm
      infants who received Bifidobacterium bifidum early after birth. In order to evaluate these
      beneficial effects of Bifidobacterium bifidum, a prospective randomized control study is
      conducted. The hypothesis of the study is that Bifidobacterium bifidum supplementation to
      preterm infants improve enteral feeding and growth in very low birth weight infants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postnatal day when enteral feeding exceeded at 100ml/kg/day</measure>
    <time_frame>From birth untill the date of enteral feeding first exceeded at 100ml/kg/day or date of death from any cause, whichever came first, assesed up to 27 days after birth</time_frame>
    <description>Death or unsuccessful of establishing enteral feeding exceeded at 100ml/kg/day before day 28 of age is considered failure to reach primary endpoint.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>standard deviation(SD) scores of bodyweight(BW) and head circumference(HC)</measure>
    <time_frame>For the duration of NICU stay, an expected average of 3 months</time_frame>
    <description>BW gain/day, SD scores of BW and HC at discharge from NICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotizing enterocolitis or sepsis</measure>
    <time_frame>For the duration of NICU stay, an expected average of 3 months</time_frame>
    <description>The incidences of necrtizing enterocolitis or sepsis during the stay in NICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal flora</measure>
    <time_frame>For the duration of NICU stay, an expected average of 3 months</time_frame>
    <description>Intestinal flora during the stay in NICU</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">246</enrollment>
  <condition>Preterm Infants</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifidobacterium bifidum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dextrin without Bifidobacterium bifidum</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bifidobacterium bifidum supplementation</intervention_name>
    <description>Bifidobacterium bifidum supplementation wiht approximately 2.5*10to9th bacteria per day</description>
    <arm_group_label>Active</arm_group_label>
    <other_name>Bifidobacterium bifidum OLB6378</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo contains dextrin</intervention_name>
    <description>0.5 of dextrin</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants with birth weight less than 1500g

        Exclusion Criteria:

          -  Sever bacteremia

          -  Congenital anomaly

          -  Not suitable for the trial defined by an attending neonatologist
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>48 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Satoshi Kusuda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tokyo Women's Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tokyo Women's Medical Unversity</name>
      <address>
        <city>Shinjuku</city>
        <state>Tokyo</state>
        <zip>162-8666</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2011</study_first_submitted>
  <study_first_submitted_qc>June 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2011</study_first_posted>
  <last_update_submitted>March 28, 2012</last_update_submitted>
  <last_update_submitted_qc>March 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tokyo Women's Medical University</investigator_affiliation>
    <investigator_full_name>Satoshi Kusuda</investigator_full_name>
    <investigator_title>Professor of Neonatology</investigator_title>
  </responsible_party>
  <keyword>probiotics</keyword>
  <keyword>preterm infants</keyword>
  <keyword>enteral feeding</keyword>
  <keyword>Bifidobacterium on enteral feeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

